Anti-human IFN-gamma mAb (1-D1K), unconjugated
3420-3
ApplicationsELISA, ELISpot Assay, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetIFNG
Overview
- SupplierMabtech
- Product NameAnti-human IFN-gamma mAb (1-D1K), unconjugated
- Delivery Days Customer9
- ApplicationsELISA, ELISpot Assay, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1-D1K
- ConjugateUnconjugated
- Gene ID3458
- Target nameIFNG
- Target descriptioninterferon gamma
- Target synonymsIFG; IFI; IFN-gamma; IMD69; immune interferon; interferon gamma
- HostMouse
- IsotypeIgG1
- ReactivityHuman
- UNSPSC12352203
References
- Meng, Q., et al. (2016). Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. J Immunother.Read more
- Sahin, U., et al. (2017). Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature.Read more
- Lunemann, J. D., et al. (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. The Journal of experimental medicine.Read more
- Ott, P. A., et al. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature.Read more
- Kranz, L. M., et al. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature.Read more